Federal contractor · public award history

IIT RESEARCH INSTITUTE

UEIDGBUFQYMKWB5CAGE03889SAM ActiveCHICAGO, ILLINOIS

Parent: IIT RESEARCH INSTITUTE DGBUFQYMKWB5

Awards we know about
21
Typical size
$765,995
Middle of their public awards
Dollars on those awards
$21.14M

Most of their awards we can see fall roughly between $438,148 and $1.98M.

SAM.gov registration

Public extract 2026-07-05

Status
Active
Purpose of registration
All awards (Z2)
Registration expires
Sep 10, 2026
Activation date
Sep 12, 2025
Primary NAICS (SAM)
541715

Other NAICS on file

Business types (SAM)

Non-Profit OrganizationA8

Entity website

Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.

From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.

Awarding agencies

  • Department of Health and Human Services (21)

Industries & product codes

Award history

  • Department of Health and Human Services$2.44M
    Sep 29, 2025PIID 75A50118F33002NAICS 541711PSC AN13AWARDUSAspending ↗

    IGF::OT::IGF

  • Department of Health and Human Services$401,373
    Sep 25, 2025PIID 75N95025F00001NAICS 541715PSC AJ11AWARDUSAspending ↗

    PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES

  • Department of Health and Human Services$568,068
    Sep 22, 2025PIID 75N91024F00003NAICS 541715PSC AN12AWARDUSAspending ↗

    TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102

  • Department of Health and Human Services$1.74M
    Sep 16, 2025PIID 75N91020F00001NAICS 541714PSC AN12AWARDUSAspending ↗

    PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER

  • Department of Health and Human Services$1.16M
    Sep 16, 2025PIID 75N91020F00001NAICS 541714PSC AN12AWARDUSAspending ↗

    TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022

  • Department of Health and Human Services$1.98M
    Jul 30, 2025PIID 75N91018F00005NAICS 541711PSC R499AWARDUSAspending ↗

    IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)

  • Department of Health and Human Services$201,969
    Jun 2, 2025PIID 75N95024F00004NAICS 541715PSC AJ11AWARDUSAspending ↗

    IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2

  • Department of Health and Human Services$1.79M
    May 8, 2025PIID 75N91024F00002NAICS 541715PSC AN12AWARDUSAspending ↗

    TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531

  • Department of Health and Human Services$656,577
    May 6, 2025PIID 75N91023F00001NAICS 541714PSC AN12AWARDUSAspending ↗

    BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013

  • Department of Health and Human Services$3,000
    Apr 30, 2025PIID 75N91022F00001NAICS 541715PSC AN12AWARDUSAspending ↗

    CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS"

  • Department of Health and Human Services$765,995
    Apr 29, 2025PIID 75N95022F00001NAICS 541712PSC AN11AWARDUSAspending ↗

    NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION

  • Department of Health and Human Services$3.16M
    Mar 13, 2025PIID 75N91022C00010NAICS 541715PSC AN12AWARDUSAspending ↗

    PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

  • Department of Health and Human Services$166,716
    Feb 25, 2025PIID 75N95024F00001NAICS 541715PSC AJ11AWARDUSAspending ↗

    IITRI - PERFORMANCE AREA 1 TO2

  • Department of Health and Human Services$512,266
    Feb 10, 2025PIID 75N95024F00002NAICS 541715PSC AN11AWARDUSAspending ↗

    FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

  • Department of Health and Human Services
    Jan 31, 2025PIID 75N91024D00001NAICS 541714PSC AN12IDVUSAspending ↗

    PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING

  • Department of Health and Human Services$3.05M
    Jan 16, 2025PIID 75N95020F00001NAICS 541712PSC AN11AWARDUSAspending ↗

    NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.

  • Department of Health and Human Services
    Jan 15, 2025PIID HHSN261201500024INAICS 541711PSC R499IDVUSAspending ↗

    IGF::OT::IGF ICIQ CONTRACT TITLED PRECLINICAL PREVENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY

  • Department of Health and Human Services$2.37M
    Dec 19, 2024PIID 75N95020F00002NAICS 541712PSC AN11AWARDUSAspending ↗

    TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.

  • Department of Health and Human Services
    Dec 18, 2024PIID 75N91019D00013NAICS 541714PSC AN12IDVUSAspending ↗

    BASE IDIQ CONTRACT FOR "PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: TOXICOLOGY AND PHARMACOLOGY TESTING"; POP: 1/25/2019-1/24/2024.

  • Department of Health and Human Services
    Dec 17, 2024PIID 75N91019D00012NAICS 541714PSC AN12IDVUSAspending ↗

    PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019-1/24/2024).

  • Department of Health and Human Services$438,148
    Nov 5, 2024PIID 75N95024F00002NAICS 541715PSC AJ11AWARDUSAspending ↗

    IITRI - PTTP DRF BPN STUDY - TO3

Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.

Related open government contracts

Industry 541715

Open SAM.gov notices in industries where this company has public awards — not exclusive work for this firm.